ICON

Automotive Aftermarkets Leader Meyer Distributing Partners with Altor to Distribute the ICON Trailer Lock

Retrieved on: 
火曜日, 5月 7, 2024
Common, ICON, Wholesaling, Marketing, Brinell scale, Intermodal freight transport

Meyer chose to offer the Altor ICON Trailer Lock because it keeps trailers safe.

Key Points: 
  • Meyer chose to offer the Altor ICON Trailer Lock because it keeps trailers safe.
  • After getting a hands on look at the ICON coupler lock we were immediately convinced this was a product we needed to partner with.
  • The quality and security is evident once you get your hands on it.” said Ben Johnson, Category Sales Manager RV Towing & Marine for Meyer Distributing.
  • The ICON Trailer Lock Review - Towing expert and influencer Mr. Truck called the ICON Trailer Lock "the best lock you can buy" after he "tests, tortures, and reviews" it.

New Leadership Elected at USRA's Council of Institutions

Retrieved on: 
木曜日, 5月 2, 2024
Education, USRA, University, Utah State University, International Society, Intelligence, Intelligence community, IPC, SDL, NASA, USU, ICON, AWE, SPIE, Conference, Research, OSIRIS-REx, National Association, Lehigh University, COI, Universities Space Research Association, STEM, Inclusion, Environment, Council, Region, PACE, Government, Faculty, NEO Surveyor, Diversity, Issue, Optics, Sunrise, Nursing

WASHINGTON, May 2, 2024 /PRNewswire/ -- The Council of Institutions (COI) of Universities Space Research Association, which comprises representatives from each of USRA's 120 member institutions, elected new leadership, bringing together esteemed professionals from diverse academic backgrounds to further advance the organization's mission.

Key Points: 
  • WASHINGTON, May 2, 2024 /PRNewswire/ -- The Council of Institutions (COI) of Universities Space Research Association, which comprises representatives from each of USRA's 120 member institutions, elected new leadership, bringing together esteemed professionals from diverse academic backgrounds to further advance the organization's mission.
  • Dr. Joan Ramage, hailing from Lehigh University, assumes the role of Chair of the Council of Institutions, while Dr. Jed Hancock, representing Utah State University, steps into the position of Vice Chair.
  • Dr. Joan Ramage's tenure with USRA dates to 2012 when she first joined as a COI representative.
  • Recognized for her leadership, Ramage was elected Vice Chair of USRA's Council of Institutions in 2022, a testament to her commitment to advancing collaborative efforts within the organization.

Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
水曜日, 5月 1, 2024
Deployment, Clinical trial, Investment, Safety, ICON, Machine learning, QIAGEN, Data and information visualization, Collection, Table, Research, Artificial intelligence, Component, ICON PLC, Intelligence, Drug discovery, ChromeOS, Patient, Data collection, Data management, SGS, Health, Drug development, Biomarker, Growth, Pharmaceutical industry

PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.

Key Points: 
  • PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.
  • Clinical trial analytics services are revolutionizing the landscape of medical research and drug development across the globe by utilizing cutting-edge data analytics and statistical methodologies to offer invaluable insights from clinical trial data.
  • The Americas lead the market with robust clinical trial activity, supported by Europe's push for more transparent and unified trial regulations.
  • "Dive into the Clinical Trial Analytics Services Market Landscape: Explore 184 Pages of Insights, 574 Tables, and 26 Figures"

Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
水曜日, 5月 1, 2024
Deployment, Clinical trial, Investment, Safety, ICON, Machine learning, QIAGEN, Data and information visualization, Collection, Table, Research, Artificial intelligence, Component, ICON PLC, Intelligence, Drug discovery, ChromeOS, Patient, Data collection, Data management, SGS, Health, Drug development, Biomarker, Growth, Pharmaceutical industry

PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.

Key Points: 
  • PUNE, India, April 30, 2024 /PRNewswire/ -- The report titled " Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment - Global Forecast 2024-2030 " is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.
  • Clinical trial analytics services are revolutionizing the landscape of medical research and drug development across the globe by utilizing cutting-edge data analytics and statistical methodologies to offer invaluable insights from clinical trial data.
  • The Americas lead the market with robust clinical trial activity, supported by Europe's push for more transparent and unified trial regulations.
  • "Dive into the Clinical Trial Analytics Services Market Landscape: Explore 184 Pages of Insights, 574 Tables, and 26 Figures"

NetLogistik to Give 3 Presentations and Host Hospitality Dinner at Blue Yonder ICON 2024

Retrieved on: 
木曜日, 4月 25, 2024
Cloud, Blue Yonder, NetSuite, ICON, Convention center, Texas Station, Booth, Snowflake, WMS, System, ABB, Third-party logistics, TMS

DENVER, April 25, 2024 (GLOBE NEWSWIRE) -- NetLogistik , a leading provider of transformative services for supply chain digitalization, announces its participation in the Blue Yonder ICON 2024 conference, scheduled for May 13-16, 2024, at the Gaylord Texan in Grapevine, Texas.

Key Points: 
  • DENVER, April 25, 2024 (GLOBE NEWSWIRE) -- NetLogistik , a leading provider of transformative services for supply chain digitalization, announces its participation in the Blue Yonder ICON 2024 conference, scheduled for May 13-16, 2024, at the Gaylord Texan in Grapevine, Texas.
  • At this event, NetLogistik will deliver three insightful presentations focusing on innovative strategies and technologies that enhance supply chain efficiency and drive value.
  • Additionally, NetLogistik is proud to be a silver sponsor of ICON and will showcase its award-winning solutions at Booth 218 during the conference.
  • An exclusive 3PL dinner reception co-hosted by NetLogistik and Blue Yonder will occur on Tuesday, May 14, 2024, at the Texas Station, 19th Hole, from 6:00 to 8:00 PM.

Leading the Industry in Sides, eXp Realty Celebrates Its Agents' Remarkable Achievements With the Top Producers Lists for 2023

Retrieved on: 
火曜日, 4月 16, 2024
ICON, Exp, Video game

“Success in this industry requires grit, agility, and a client-focused approach – qualities that each member of this prestigious ranking has exemplified.

Key Points: 
  • “Success in this industry requires grit, agility, and a client-focused approach – qualities that each member of this prestigious ranking has exemplified.
  • 1 spot in both volume and sides once again with $599,749,884 in sales and an impressive 954 sides.
  • Leading in individual sales volume is Gary Geng, an eXp Realty agent based in Vancouver, British Columbia.
  • NRG powered by eXp from South Africa reached the top of international team sides with a count of 186 transactions.

Companies Can “Superpower” Their Supply Chains at Blue Yonder ICON, the Premier Industry Conference

Retrieved on: 
火曜日, 4月 23, 2024
Data Management, Other Retail, Supply Chain Management, Technology, Other Transport, Trucking, Transport, Retail, Software, Artificial Intelligence, Logistics, Diamond, ICON, ONEREPUBLIC, Rossell, Altria, Devon Walker, Area studies, Micron Technology, Limited, AB InBev, Tractor Supply Company, Ardagh Group, Crate, Woman, Dawn Foods, Uncertainty, Federated, Pro Bowl, CNBC, Workforce, ODL, New Orleans Saints, Ecosystem, Shark Tank, Coca-Cola FEMSA, Dollar General, Chain, AG, Ferrara Candy Company, Microsoft, Squawk Box, ABB, Crate & Barrel, UX, Commerce, Bayer, Software as a service, Caterpillar Inc., CONA, Alcon, DENSO, Final good, Accenture, Nightclub

That’s why Blue Yonder , a leader in digital supply chain transformations, is inviting them to attend ICON 2024 – the premier conference for supply chain leaders in manufacturing, logistics and retail – taking place in Dallas, May 13-16, 2024.

Key Points: 
  • That’s why Blue Yonder , a leader in digital supply chain transformations, is inviting them to attend ICON 2024 – the premier conference for supply chain leaders in manufacturing, logistics and retail – taking place in Dallas, May 13-16, 2024.
  • Rossell will look at the current state of global supply chains and the inflection point that the industry is facing.
  • Engage with 56 Blue Yonder ecosystem partners and learn how their technology enhances Blue Yonder’s supply chain and commerce solutions.
  • Meet with the Composable Journey team to understand how to accelerate their route to an autonomous supply chain through Blue Yonder innovation.

Navigate Placebo Response: Insights and Mitigation Strategies for Clinical Excellence, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
水曜日, 4月 10, 2024
University, ICON, Drug, MD, Panel discussion, Doctor of Philosophy, Research, Internet, Senior, ICON PLC, Maryland School, Pharmaceutical industry

TORONTO, April 10, 2024 /PRNewswire-PRWeb/ -- Cognivia has convened Key Opinion Leaders (KOLs) from academia, industry and service sectors for an exclusive Panel Discussion on Placebo Response. Attendees will delve into the forefront of placebo response research and mitigation tactics within contemporary clinical trials. Experts will dissect the placebo response phenomenon and offer insights right from the latest biological research to pragmatic methodologies for trial success.

Key Points: 
  • In this free webinar, discover the key ideas to mastering placebo responses in clinical trials in 2024 and beyond.
  • Attendees will learn about the latest biological insights and pragmatic mitigation strategies for trial success.
  • Attendees will gain valuable insights from industry and academic leaders to achieve success in modern clinical development.
  • Attendees will delve into the forefront of placebo response research and mitigation tactics within contemporary clinical trials.

Hong Kong Ferry announces FY2023 annual results Increase in revenue for FY2023 Sales on completed existing units of The Symphonie

Retrieved on: 
水曜日, 4月 10, 2024
Health, Shipyard, Consolidated, Urology, Cardiology, Patient, ICON, Spectacle, Sale, Transport Department, Seemabaddha, Tung, Point, HK25, Holding, Rheumatology, Elective surgery, Mira Place, Property management

Consolidated profit after taxation for FY2023 amounted to HK$186 million, down by approximately 86% as compared to last year.

Key Points: 
  • Consolidated profit after taxation for FY2023 amounted to HK$186 million, down by approximately 86% as compared to last year.
  • （22 March 2024, Hong Kong） – Hong Kong Ferry (Holdings) Company Limited (the “Company”, which together with its subsidiaries, is referred to as the “Group”; SEHK stock code: 0050) announced annual results for the year ended 31 December 2023.
  • The revenue and operating profit for the year were mainly derived from the rental income from shops and commercial arcades as well as interest income from banks.
  • Mr. Gabriel Lee, General Manager of Hong Kong Ferry, said, “The Hong Kong Ferry Group has been established for 100 years in 2023, and the Group has successfully transformed itself from a ferry and shipyard focused business into an integrated conglomerate.

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Retrieved on: 
火曜日, 4月 2, 2024
Independent, Business school, Bachelor of Science, Engineering, Bristol Myers Squibb, Thayer School of Engineering, Immunology, Therapy, Corporate development, Corporation, True north, ICON PLC, Business, Dartmouth College, Biogen, ATP, Genzyme, Cardiology, Biomedical engineering, Novo Nordisk, Drug discovery, Tuck School of Business, Acquisition, University, MBBS, AbbVie, Bioverativ, ICON, CBO, Columbia University, Biology, MBA, Hidradenitis suppurativa, TRML, Partner, Military, Management

The Avalo Board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development.

Key Points: 
  • The Avalo Board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development.
  • The recent board appointments include Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors.
  • He has spent over a decade specializing in founding, building and investing in biotech companies.
  • Samantha also chairs the Board of Advisors for Thayer School of Engineering at Dartmouth and is a member of the Board of Advisors for Life Science Cares.